NSAID-sensitive patients tolerate rofecoxib.
Valero
A
A
Servei de Pneumologia i Allergia Respiratoria, Hospital Clinic, Villarroel, 17008036, Barcelona, Spain. cpicado@medicina.ub.es
Baltasar
M
M
Enrique
E
E
Pau
L
L
Dordal
M T
MT
Cisteró
A
A
Martí
E
E
Picado
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000799:Angioedema / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000503:physiopathology; D004361:Drug Tolerance; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate / Q000502:physiology; D016037:Single-Blind Method; D013450:Sulfones; D014581:Urticaria / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib